Seminars in Nephrology

Journal

Publication Venue For

  • Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.  38:461-476. 2018
  • Apolipoprotein L1 Gene Effects on Kidney Transplantation.  37:530-537. 2017
  • Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.  36:252-261. 2016
  • Targeting Iron Homeostasis in Acute Kidney Injury.  36:62-70. 2016
  • Endothelin and Renal Ion and Water Transport.  35:137-144. 2015
  • Endothelin and the Renal Microcirculation.  35:145-155. 2015
  • Pathophysiology and Treatment of Resistant Hypertension: The Role of Aldosterone and Amiloride-Sensitive Sodium Channels.  34:532-539. 2014
  • Fibroblast growth factor 23, vitamin d, and health disparities among african americans with chronic kidney disease.  33:448-456. 2013
  • Arteriovenous Fistula Failure: Is There a Role for Epigenetic Regulation?.  33:400-406. 2013
  • Genetic disorders of potassium homeostasis.  33:300-309. 2013
  • Chronic Kidney Disease in African Americans: Past, Present, and Future: Introduction.  33:407-408. 2013
  • Balloon-Assisted Maturation (BAM) of the Arteriovenous Fistula: The Good, the Bad, and the Ugly.  32:558-563. 2012
  • Effect of Dietary Salt on Regulation of TGF-β in the Kidney.  32:269-276. 2012
  • Heme Oxygenase-1 as a Target for TGF-β in Kidney Disease.  32:277-286. 2012
  • Uric Acid and Hypertension.  31:441-446. 2011
  • Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis.  30:164-176. 2010
  • IgA Glycosylation and IgA Immune Complexes in the Pathogenesis of IgA Nephropathy.  28:78-87. 2008
  • Diagnostic Tools for Monitoring Kidney Transplant Recipients.  27:462-478. 2007
  • Uric acid and hypertension in adolescents.  25:32-38. 2005
  • Angiotensin II Receptor Type 1 Expression in Erythroid Progenitors: Implications for the Pathogenesis of Postrenal Transplant Erythrocytosis.  24:120-130. 2004
  • Oxidative Stress in Hypertension and Chronic Kidney Disease: Role of Angiotensin II.  24:101-114. 2004
  • Issues related to iron replacement in chronic kidney disease.  22:479-487. 2002
  • Genetic renal tubular disorders of renal ion channels and transporters.  21:81-93. 2001
  • Prevention, protection, and the intrarenal renin-angiotensin systems.  21:593-602. 2001
  • Risk and benefit of coronary revascularization in renal transplant candidates.  21:47-51. 2001
  • Treatment of IgA nephropathy.  20:277-285. 2000
  • Low renin hypertension in the next millennium.  20:40-46. 2000
  • Genetic testing for patients with renal disease: Procedures, pitfalls, and ethical considerations.  19:319-326. 1999
  • Hypertension.  19:374-380. 1999
  • Possible mediators in hypertension: Renal factors.  16:134-139. 1996
  • Monoclonal immunoglobulin light chain-related renal diseases.  13:324-341. 1993
  • Mechanism of H+ secretion in the proximal convoluted tubule.  10:93-103. 1990
  • Analysis of immunoglobulin heavy chain restriction fragment length polymorphisms in IgA nephropathy..  7:306-310. 1987
  • IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions..  7:332-335. 1987
  • Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy..  7:389-392. 1987
  • Intrarenal feedback control of glomerular filtration rate.  2:289-301. 1982
  • International Standard Serial Number (issn)

  • 0270-9295
  • Electronic International Standard Serial Number (eissn)

  • 1558-4488